Literature DB >> 20551163

The role of histamine degradation gene polymorphisms in moderating the effects of food additives on children's ADHD symptoms.

Jim Stevenson1, Edmund Sonuga-Barke, Donna McCann, Kate Grimshaw, Karen M Parker, Matthew J Rose-Zerilli, John W Holloway, John O Warner.   

Abstract

OBJECTIVE: Food additives can exacerbate ADHD symptoms and cause non-immunoglobulin E-dependent histamine release from circulating basophils. However, children vary in the extent to which their ADHD symptoms are exacerbated by the ingestion of food additives. The authors hypothesized that genetic polymorphisms affecting histamine degradation would explain the diversity of responses to additives.
METHOD: In a double-blind, placebo-controlled crossover trial, challenges involving two food color additive and sodium benzoate (preservative) mixtures in a fruit drink were administered to a general community sample of 3-year-old children (N = 153) and 8/9-year-old children (N = 144). An aggregate ADHD symptom measure (based on teacher and parent blind ratings of behavior, blind direct observation of behavior in the classroom, and--for 8/9-year-old children only--a computerized measure of attention) was the main outcome variable.
RESULTS: The adverse effect of food additives on ADHD symptoms was moderated by histamine degradation gene polymorphisms HNMT T939C and HNMT Thr105Ile in 3- and 8/9-year-old children and by a DAT1 polymorphism (short versus long) in 8/9-year-old children only. There was no evidence that polymorphisms in catecholamine genes COMT Val108Met, ADRA2A C1291G, and DRD4-rs7403703 moderated the effect on ADHD symptoms.
CONCLUSIONS: Histamine may mediate the effects of food additives on ADHD symptoms, and variations in genes influencing the action of histamine may explain the inconsistency between previous studies. Genes influencing a range of neurotransmitter systems and their interplay with environmental factors, such as diet, need to be examined to understand genetic influences on ADHD symptoms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20551163     DOI: 10.1176/appi.ajp.2010.09101529

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  24 in total

1.  Future directions in ADHD etiology research.

Authors:  Joel T Nigg
Journal:  J Clin Child Adolesc Psychol       Date:  2012-05-29

2.  Where Do Epigenetics and Developmental Origins Take the Field of Developmental Psychopathology?

Authors:  Joel T Nigg
Journal:  J Abnorm Child Psychol       Date:  2016-04

3.  A literature search tool for intelligent extraction of disease-associated genes.

Authors:  Jae-Yoon Jung; Todd F DeLuca; Tristan H Nelson; Dennis P Wall
Journal:  J Am Med Inform Assoc       Date:  2013-09-02       Impact factor: 4.497

4.  Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials.

Authors:  Elizabeth Hawkey; Joel T Nigg
Journal:  Clin Psychol Rev       Date:  2014-06-02

5.  Environment, developmental origins, and attention-deficit/hyperactivity disorder.

Authors:  Joel Nigg
Journal:  Arch Pediatr Adolesc Med       Date:  2012-01-02

6.  Non-Pharmacological Treatments for ADHD in Youth.

Authors:  Anup Sharma; Patricia L Gerbarg; Richard P Brown
Journal:  Adolesc Psychiatry (Hilversum)       Date:  2015

7.  Evaluation of dietary intake in children and college students with and without attention-deficit/hyperactivity disorder.

Authors:  Kathleen F Holton; Jeanette M Johnstone; Elizabeth T Brandley; Joel T Nigg
Journal:  Nutr Neurosci       Date:  2018-01-23       Impact factor: 4.994

8.  Embryonic exposure to valproic acid affects the histaminergic system and the social behaviour of adult zebrafish (Danio rerio).

Authors:  Diego Baronio; Henri A J Puttonen; Maria Sundvik; Svetlana Semenova; Essi Lehtonen; Pertti Panula
Journal:  Br J Pharmacol       Date:  2018-01-23       Impact factor: 8.739

Review 9.  Broad-spectrum micronutrient treatment for attention-deficit/hyperactivity disorder: rationale and evidence to date.

Authors:  Julia J Rucklidge; Bonnie J Kaplan
Journal:  CNS Drugs       Date:  2014-09       Impact factor: 5.749

Review 10.  Attention deficits and hyperactivity-impulsivity: what have we learned, what next?

Authors:  Joel T Nigg
Journal:  Dev Psychopathol       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.